What the company does
Ipsen S.A., a biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide. Its oncology products include Somatuline for the treatment of neuroendocrine tumors and acromegaly; Cabometyx, a tyrosine kinase inhibitor to treat second line pancreatic and extra-pancreatic neuroendocrine tumors; Onivyde, an irinotecan liposome injection for the treatment of pancreatic cancer; Decapeptyl for the treatment of advanced metastatic prostate cancer; Tazverik, a chemotherapy-free EZH2a inhibitor that is in phase III clinical trial for the treatment of second line follicular lymphoma; Tovorafenib that is in phase III clinical trial to …
What the weekly tape is saying
IPN closed the latest completed week at 157.4 EUR. The 4-week return is -4.6% and the 12-week return is 5.1%. Trend Signal is active, Market Dynamics is -0.76. Setup signature: Risk-first tape with a 40/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 146.6 EUR
- Vs Trend Line
- 7.4%
- Fair Value
- 116.7 EUR
- Vs Fair Value
- 34.9%
- 52W High
- 171.3 EUR
- 52W Low
- 100.4 EUR
- Drawdown
- -8.1%
- Range Position
- 80.4%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 42 weeks
- 52W Active Weeks
- 42
- 52W Active Breadth
- 80.8%
- Sector Scope
- AT Healthcare
- Sector Rank
- 45 of 112
- Sector Percentile
- 60.4%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
AT Healthcare
- Tracked Peers
- 100
- 4W Rank
- 89 of 100
- Avg 1W
- -1.0%
- Avg 4W
- 3.6%
- Trend Breadth
- 35.0%
- Positive MD
- 42.0%
AT Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 16
- 4W Rank
- 13 of 16
- Avg 1W
- -0.1%
- Avg 4W
- 0.6%
- Trend Breadth
- 56.3%
- Positive RS
- 25.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.76
- 4W MD Change
- -711.0%
- Relative Strength
- -1.73
- 4W RS Change
- -115.9%
- Expectation
- Undecided
- Probability
- 47.22%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 0
- 13W Average
- 0
- 52W Average
- 18
- Vs 13W
- -
- Vs 52W
- -
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 2.9%
- 52W Volatility
- 3.7%
- Upside Weeks
- 28
- Downside Weeks
- 24
- Downside Breadth
- 46.2%
- Avg Gain / Loss
- 3.5% / -2.2%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- VIE
- Country
- AT
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- EUR
- Market Cap
- 12.7B
Opportunity signals
- Trend Signal is active with a 42-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
Risk signals
- Market Dynamics is negative, which weakens the current setup.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 157.4 EUR | -0.1% | 146.6 EUR | 116.7 EUR | -0.76 | -1.73 | 0 | On |
| 5 Jun 2026 | 157.5 EUR | 2.6% | 145.7 EUR | 116.4 EUR | -0.58 | 1.27 | 0 | On |
| 29 May 2026 | 153.5 EUR | -3.1% | 144.6 EUR | 116.1 EUR | -0.37 | -2.18 | 0 | On |
| 22 May 2026 | 158.3 EUR | -4.1% | 143.5 EUR | 115.8 EUR | -0.10 | 3.85 | 0 | On |
| 15 May 2026 | 165.0 EUR | -0.2% | 142.3 EUR | 115.5 EUR | 0.12 | 10.85 | 0 | On |
| 8 May 2026 | 165.3 EUR | 0.8% | 140.6 EUR | 115.1 EUR | 0.23 | 11.06 | 0 | On |
| 1 May 2026 | 164.1 EUR | 1.2% | 139.0 EUR | 114.7 EUR | 0.52 | 12.29 | 0 | On |
| 24 Apr 2026 | 162.2 EUR | 1.4% | 137.4 EUR | 114.3 EUR | 0.72 | 12.09 | 0 | On |
| 17 Apr 2026 | 160.0 EUR | -4.0% | 135.7 EUR | 114.0 EUR | 0.87 | 7.15 | 0 | On |
| 10 Apr 2026 | 166.6 EUR | 2.7% | 134.2 EUR | 113.6 EUR | 0.93 | 14.69 | 0 | On |
| 3 Apr 2026 | 162.3 EUR | 3.0% | 132.6 EUR | 113.2 EUR | 0.88 | 19.35 | 0 | On |
| 27 Mar 2026 | 157.5 EUR | 5.2% | 131.2 EUR | 112.8 EUR | 0.94 | 20.15 | 0 | On |
| 20 Mar 2026 | 149.7 EUR | -3.5% | 129.9 EUR | 112.4 EUR | 1.02 | 16.26 | 0 | On |
| 13 Mar 2026 | 155.1 EUR | -4.9% | 128.8 EUR | 112.1 EUR | 1.15 | 19.19 | 0 | On |